Immunogenic compositions comprising lawsonia intracellularis
AssigneeBoehringer Ingelheim Animal Health USA Inc.
InventorsJeremy KROLL, Mike ROOF
Life of this patent
Estimating the term…
Abstract
The present invention provides combination vaccines that comprise an immunological agent effective for reducing the incidence of or lessening the severity of PPE caused by L. intracellularis, and one or more immunological active components effective in treatment and/or prophylaxis of at least one further disease-causing organism for swine. Moreover, the present invention also relates to a kit that comprises an immunological agent effective for reducing the incidence of or lessening the severity of PPE caused by L. intracellularis, and one or more immunological active components effective in treatment and/or prophylaxis of at least one further disease-causing organism for swine.
Claims13
A method for the prophylaxis or treatment of diseases caused by Lawsonia intracellularis, and one or more further swine pathogenic microorganism(s), wherein Lawsonia intracellularis bacterium antigen is administered to a non-human animal in need thereof together with at least two components of a further disease-causing organism for swine selected from the group consisting of:
- (i) killed Lawsonia intracellularis bacterium,
- (ii) killed Mycoplasma hyopneumoniae, and
- (iii) Porcine circovirus.
Dependencies are inferred from the claim text.